1. Home
  2. RNR vs ICLR Comparison

RNR vs ICLR Comparison

Compare RNR & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenaissanceRe Holdings Ltd.

RNR

RenaissanceRe Holdings Ltd.

N/A

Current Price

$323.44

Market Cap

13.6B

Sector

Finance

ML Signal

N/A

Logo ICON plc

ICLR

ICON plc

N/A

Current Price

$161.65

Market Cap

13.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RNR
ICLR
Founded
1993
1990
Country
Bermuda
Ireland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6B
13.1B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
RNR
ICLR
Price
$323.44
$161.65
Analyst Decision
Hold
Buy
Analyst Count
18
18
Target Price
★ $347.56
$185.82
AVG Volume (30 Days)
242.8K
★ 967.5K
Earning Date
10-27-2026
10-21-2026
Dividend Yield
★ 0.52%
N/A
EPS Growth
★ 59.13
N/A
EPS
★ 6.57
N/A
Revenue
★ $12,848,074,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.69
P/E Ratio
$49.62
★ $12.91
Revenue Growth
★ 9.86
N/A
52 Week Low
$231.17
$66.57
52 Week High
$340.24
$203.91

Technical Indicators

Market Signals
Indicator
RNR
ICLR
Relative Strength Index (RSI) 41.04 49.06
Support Level $316.11 $162.32
Resistance Level $333.73 $180.07
Average True Range (ATR) 5.86 6.07
MACD -1.24 0.05
Stochastic Oscillator 15.65 33.62

Price Performance

Historical Comparison
RNR
ICLR

About RNR RenaissanceRe Holdings Ltd.

RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: